Loperamide Dosing Recommendations
For adults and children 13 years and older, start with 4 mg initially, then 2 mg after each unformed stool, not exceeding 16 mg per day; for children 2-12 years, use age-based dosing starting at 1-2 mg three times daily on day one, followed by 1 mg per 10 kg after loose stools. 1
Adult Dosing (≥13 Years)
Acute Diarrhea
- Initial dose: 4 mg (two capsules), followed by 2 mg after each unformed stool 2, 3, 1
- Alternative approach: 2 mg every 2-4 hours if preferred over the "after each stool" method 2, 3
- Maximum daily dose: 16 mg (eight capsules) 2, 3, 1
- Clinical improvement typically occurs within 48 hours 1
Chronic Diarrhea
- Same initial dosing: 4 mg followed by 2 mg after each unformed stool until controlled 1
- Once optimal dosage is established, may be given as single daily dose or divided doses 1
- Average maintenance dose: 4-8 mg per day 1
- Maximum remains 16 mg per day 1
- If no improvement after 10 days at 16 mg/day, further treatment unlikely to help 1
Pediatric Dosing (2-12 Years)
First Day Dosing Schedule
- Ages 2-5 years (13-20 kg): 1 mg three times daily (3 mg total) 1
- Ages 6-8 years (20-30 kg): 2 mg twice daily (4 mg total) 1
- Ages 8-12 years (>30 kg): 2 mg three times daily (6 mg total) 1
- For children 2-5 years, use liquid formulation (1 mg/5 mL) rather than capsules 1
Subsequent Days
- Give 1 mg per 10 kg body weight only after a loose stool 1
- Do not exceed the first day's total dosage 1
Critical Safety Considerations
Absolute Contraindications
- Children under 2 years of age due to respiratory depression and cardiac risks 1
- Grade 3-4 immunotherapy-induced diarrhea 2, 3
- Neutropenic enterocolitis (avoid all antimotility agents) 3
When to Avoid or Use Extreme Caution
- Bloody diarrhea or suspected dysentery without antibiotic coverage 3
- Fever, moderate to severe abdominal pain, or signs of severe dehydration warrant hospitalization with IV fluids rather than loperamide alone 2, 3
- Hepatic impairment (use cautiously due to reduced metabolism and increased systemic exposure) 1
- Elderly patients on QT-prolonging drugs (Class IA or III antiarrhythmics) 1
Cardiac Safety Warning
- Never exceed 16 mg per day—serious cardiac events including QT prolongation, torsades de pointes, cardiac arrest, and death can occur with supratherapeutic doses 2, 1
- The FDA warning primarily relates to abuse cases with doses of 64-1600 mg daily, far exceeding therapeutic dosing 4
- At recommended doses for chemotherapy-induced diarrhea, cardiac risk remains extremely low and is outweighed by risks of uncontrolled diarrhea 4
Essential Supportive Measures
- Ensure adequate fluid and electrolyte replacement 2, 3
- Implement dietary modifications: avoid lactose products, spices, coffee, alcohol, and high insoluble fiber foods 2, 3
- Consider avoiding milk and dairy except yogurt and firm cheeses 3
Common Pitfalls to Avoid
- Do not delay initiation—early intervention prevents progression to severe diarrhea 2
- Loperamide takes 1-2 hours to reach therapeutic effect, so space additional dosing accordingly to avoid rebound constipation 2
- Do not use in severe immunotherapy-induced colitis as it may worsen outcomes 2
- Monitor for signs of dehydration or worsening symptoms 2
Special Populations
Elderly
- No dose adjustment required 1
- More susceptible to QT interval effects—avoid concurrent QT-prolonging medications 1
Renal Impairment
- No dose adjustment needed (drug mainly excreted in feces) 1
Hepatic Impairment
- Use with caution due to potentially increased systemic exposure 1